(Q39416092)

11 September 2017

title

Management of protein-losing enteropathy after the Fontan procedure (English)

1 reference

protein-losing enteropathy

11 September 2017

main subject

1 reference

Jack Rychik

1

1 reference

11 September 2017

language of work or name

1 reference

1 January 1998

1 reference

Seminars in thoracic and cardiovascular surgery. Pediatric cardiac surgery annual

11 September 2017

published in

1 reference

11 September 2017

volume

1

1 reference

11 September 2017

page(s)

15-22

1 reference

Improved early morbidity and mortality after Fontan operation: the Mayo Clinic experience, 1987 to 1992

11 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1092-9126%2898%2970005-5

7 January 2021

Enteric protein loss after the Fontan operation

1 reference

https://api.crossref.org/works/10.1016%2FS1092-9126%2898%2970005-5

7 January 2021

Protein-losing enteropathy after the Fontan operation

1 reference

https://api.crossref.org/works/10.1016%2FS1092-9126%2898%2970005-5

7 January 2021

Protein-losing gastroenteropathy in congestive heart-failure

1 reference

https://api.crossref.org/works/10.1016%2FS1092-9126%2898%2970005-5

7 January 2021

Reversible Protein-Losing Enteropathy with Intestinal Lymphangiectasia Secondary to Chronic Constrictive Pericarditis

1 reference

https://api.crossref.org/works/10.1016%2FS1092-9126%2898%2970005-5

7 January 2021

Protein-losing Enteropathy after Fontan Operation for Tricuspid Atresia (Imperforate Tricuspid Valve)

1 reference

https://api.crossref.org/works/10.1016%2FS1092-9126%2898%2970005-5

7 January 2021

Protein-losing enteropathy following the Fontan operation: resolution with prednisone therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1092-9126%2898%2970005-5

7 January 2021

Usefulness of corticosteroid therapy for protein-losing enteropathy after the Fontan procedure

1 reference

https://api.crossref.org/works/10.1016%2FS1092-9126%2898%2970005-5

7 January 2021

Protein-losing enteropathy after the modified fontan operation: oral prednisone treatment with biopsy and laboratory proved improvement

1 reference

https://api.crossref.org/works/10.1016%2FS1092-9126%2898%2970005-5

7 January 2021

Reversal of protein-losing enteropathy with heparin therapy in three patients with univentricular hearts and Fontan palliation

1 reference

https://api.crossref.org/works/10.1016%2FS1092-9126%2898%2970005-5

7 January 2021

Congenital enterocyte heparan sulphate deficiency with massive albumin loss, secretory diarrhoea, and malnutrition

1 reference

https://api.crossref.org/works/10.1016%2FS1092-9126%2898%2970005-5

7 January 2021

Effect of baffle fenestration on outcome of the modified Fontan operation

1 reference

https://api.crossref.org/works/10.1016%2FS1092-9126%2898%2970005-5

7 January 2021

Hemodynamic evaluation before and after closure of fenestrated Fontan. An acute study of changes in oxygen delivery

1 reference

https://api.crossref.org/works/10.1016%2FS1092-9126%2898%2970005-5

7 January 2021

Effect of percutaneous fenestration of the atrial septum on protein-losing enteropathy after the Fontan operation

1 reference

https://api.crossref.org/works/10.1016%2FS1092-9126%2898%2970005-5

7 January 2021

Late Surgical Fenestration for Complications After the Fontan Operation

1 reference

https://api.crossref.org/works/10.1016%2FS1092-9126%2898%2970005-5

7 January 2021

Transcatheter fenestration dilation and/or creation in postoperative Fontan patients

1 reference

https://api.crossref.org/works/10.1016%2FS1092-9126%2898%2970005-5

7 January 2021

10.1016/S1092-9126(98)70005-5

Identifiers

DOI

1 reference

11 September 2017

1 reference